ClinicalTrials.Veeva

Menu

Long-term Effect of tDCS in Patients With Disorders of Consciousness

U

University of Liege

Status

Completed

Conditions

Disorder of Consciousness

Treatments

Device: transcranial direct current stimulation - sham
Device: transcranial direct current stimulation - active

Study type

Interventional

Funder types

Other

Identifiers

NCT03114397
2014/113b

Details and patient eligibility

About

In this multicentric double-blind sham controlled study, the investigators plan to assess the effects of 20 sessions of tDCS on long-term behavioral recovery in patients with disorders of consciousness. Neurophysiological outcomes (EEG) will also be collected.

This research will 1) determine whether long-term behavioral recovery can be promoted with tDCS and 2) generate knowledge regarding the impact of tDCS on neurophysiological outcome (i.e., EEG) in severely brain injured patients. The investigators will compare the effects of active and sham tDCS on behavioral assessments and quantitative EEG in patients with severe brain injury and its potential application in rehabilitation.

Enrollment

62 patients

Sex

All

Ages

16 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CNS medication stable for at least a week
  • Stable diagnosis (no diagnosis change based on 2 CRS-R performed within 1 week).
  • Between 3 and 24 months post injury
  • Structural MRI or CT-scan (to evidence focal lesions on the left DLPFC)

Exclusion criteria

  • Craniotomies encompassing the frontal region (electrodes location)
  • VPS under the stimulated area (prefrontal cortex)
  • Pacemaker
  • Metallic cerebral implant
  • Severe medical conditions that might influence clinical diagnosis and EEG activity (e.g., severe hepatic insufficiency or renal failure, or sub-continuous or abundant epileptiform discharges on standard EEG recordings).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

62 participants in 2 patient groups, including a placebo group

anodal stimulation
Active Comparator group
Description:
Patients will receive anodal tDCS (on the left dorsolateral prefrontal cortex) every day for 4 weeks, 5 days per week (tDCS of 2mA during 20minutes) for a total of 20 sessions.
Treatment:
Device: transcranial direct current stimulation - active
sham stimulation
Placebo Comparator group
Description:
Patients will receive sham tDCS (on the left dorsolateral prefrontal cortex) every day for 4 weeks, 5 days per week (tDCS of 2mA during 20minutes) for a total of 20 sessions.
Treatment:
Device: transcranial direct current stimulation - sham

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems